Shots:
- Merck Animal Health has reported data on Bovillis Nasalgen-C (Lyophilisate & Solvent for Suspension; intranasal vaccination) for the prevention of bovine coronavirus in veal calves at Vlaamse Buiatriecongres’25
- Data was presented from a study titled “Intranasal vaccination against bovine coronavirus significantly improves production parameters in cross-bred veal calves: Results from a randomized field trial”, which assessed Bovillis Nasalgen-C vs PBO in 217 male cross-bred veal calves administered upon arrival at fattening units
- Study showed improved production outcomes with fewer lung lesions & demonstrated a higher body weight (+2.88kg), plus average daily weight gain (+39g/day) after 10wks. in veal calves
Ref: Merck Animal Health | Image: Merck Animal Health | Press Release
Related News:- Merck Animal Health Reports the US FDA’s Approval of Exzolt for Northern Fowl Mites
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
